Latisse® is an FDA-approved product that has been formulated to increase eyelash growth. Longer, fuller, and darker lashes are possible with this once-nightly treatment that is applied topically to the base of the upper eyelashes. Over the span of about four weeks, an increase in length becomes noticeable, but full growth is achieved in 16 weeks. This product does not create an illusion of longer, thicker, and dark eyelashes, but it actually stimulates growth to create them!
Latisse was created by Allergan, a pharmaceutical leader with over 60 years of eye care expertise. Allergan developed a prostaglandin, a medical eye drop, to control the progression of glaucoma, an eye condition that damages the optic never, the reduction of intraocular pressure, or fluid pressure inside of the eye, and in the management of ocular hypertension, or high eye pressure, all through the outflow of aqueous fluid from the eyes. In addition to helping with their medical issues, many patients using this medication also began to notice growth and thickness in their eyelashes as a side effect. As a result, a clinical trial was held in 2008, which led to Latisse becoming approved by the FDA purely for cosmetic purposes.
Latisse’s active ingredient, bimatoprost, is responsible for lash growth, by affecting the hair’s growth cycle in two ways: first, it lengthens the time of this phase and second, it increases the numbers of hairs grown in this phase. Therefore, Latisse works from the inside out. As the treatment progresses, you’ll begin to see changes in the length of your eyelashes and then you’ll gradually notice more thickness and darkness. It is likely that you will be satisfied with your results by week eight, but it’s important not to stop there! By week 16, your longer, thicker, and darker .
Possible side effects
The most common side effects after using LATISSE®solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE® solution may cause other less common side effects which typically occur on the skin close to where LATISSE® is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your physician’s advice concerning the continued use of LATISSE® solution.
Special warnings associated with LATISSE® use
LATISSE® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. Refer to the illustration below. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE®under the close supervision of your physician